Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedJul 04, 2026
DataAggregated Company Financials
Companies17
  • 7D1.5%
  • 3M-5.3%
  • 1Y33.4%
  • YTD6.1%

The Pharma industry is up 1.5% in the last week, with AstraZeneca up 1.0%. During this same period, the Allergy Therapeutics underperformed, falling 5.7%. This takes the industry's 12 month performance to a gain of 33%. Looking forward, earnings are forecast to grow by 10% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 04 Jul 2026UK£342.3bUK£92.2bUK£15.9b19.3x21.6x3.7x
Mon, 01 Jun 2026UK£324.6bUK£91.8bUK£15.8b17.9x20.6x3.5x
Wed, 29 Apr 2026UK£333.6bUK£90.3bUK£15.5b18.7x21.5x3.7x
Fri, 27 Mar 2026UK£333.7bUK£90.9bUK£15.7b19.6x21.3x3.7x
Sun, 22 Feb 2026UK£368.0bUK£90.2bUK£15.4b23.5x23.9x4.1x
Tue, 20 Jan 2026UK£326.2bUK£89.5bUK£14.6b21.1x22.3x3.6x
Thu, 18 Dec 2025UK£322.1bUK£89.6bUK£14.6b21.6x22x3.6x
Sat, 15 Nov 2025UK£320.2bUK£90.4bUK£14.8b21.6x21.7x3.5x
Mon, 13 Oct 2025UK£300.1bUK£88.0bUK£11.8b19.8x25.5x3.4x
Wed, 10 Sep 2025UK£283.7bUK£87.4bUK£11.7b21.6x24.3x3.2x
Fri, 08 Aug 2025UK£263.6bUK£87.6bUK£11.4b27.3x23.1x3x
Sun, 06 Jul 2025UK£257.7bUK£86.0bUK£10.6b25.8x24.4x3x
Tue, 03 Jun 2025UK£269.6bUK£86.3bUK£10.6b27.2x25.4x3.1x
Thu, 01 May 2025UK£267.4bUK£87.0bUK£10.1b26x26.4x3.1x
Sat, 29 Mar 2025UK£280.2bUK£87.7bUK£9.7b32.6x29x3.2x
Mon, 24 Feb 2025UK£283.5bUK£88.7bUK£9.4b30.9x30x3.2x
Wed, 22 Jan 2025UK£234.5bUK£76.2bUK£7.9b32.5x29.8x3.1x
Fri, 20 Dec 2024UK£220.0bUK£75.5bUK£7.8b30.6x28.2x2.9x
Sun, 17 Nov 2024UK£215.0bUK£75.2bUK£7.8b30x27.7x2.9x
Tue, 15 Oct 2024UK£250.3bUK£72.2bUK£9.0b31.1x27.7x3.5x
Thu, 12 Sep 2024UK£265.6bUK£72.3bUK£9.0b38.6x29.4x3.7x
Sat, 10 Aug 2024UK£268.9bUK£73.2bUK£9.1b39x29.5x3.7x
Mon, 08 Jul 2024UK£256.0bUK£71.2bUK£9.5b31.6x26.9x3.6x
Wed, 05 Jun 2024UK£266.1bUK£71.3bUK£9.5b32.1x27.9x3.7x
Fri, 03 May 2024UK£266.7bUK£72.1bUK£9.6b32.9x27.7x3.7x
Sun, 31 Mar 2024UK£245.1bUK£70.8bUK£9.7b31.8x25.2x3.5x
Tue, 27 Feb 2024UK£236.5bUK£70.5bUK£9.6b33.9x24.6x3.4x
Thu, 25 Jan 2024UK£236.8bUK£68.9bUK£10.7b36.2x22.2x3.4x
Sat, 23 Dec 2023UK£232.3bUK£68.8bUK£10.7b34.9x21.8x3.4x
Mon, 20 Nov 2023UK£227.8bUK£69.7bUK£10.8b53.8x21.2x3.3x
Wed, 18 Oct 2023UK£245.1bUK£70.6bUK£10.3b56.6x23.7x3.5x
Fri, 15 Sep 2023UK£242.4bUK£69.9bUK£10.3b55.1x23.6x3.5x
Sun, 13 Aug 2023UK£241.0bUK£69.0bUK£10.2b52.8x23.7x3.5x
Tue, 11 Jul 2023UK£224.5bUK£67.4bUK£7.8b55.5x28.6x3.3x
Price to Earnings Ratio

28.6x


Total Market Cap: UK£224.5bTotal Earnings: UK£7.8bTotal Revenue: UK£67.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 25.1x202420252026
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 21.6x which is lower than its 3-year average PE of 25.1x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 26% per year over the last three years.
  • Revenues for these companies have grown 11% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market1.61%
Healthcare1.40%
Pharma1.48%
Pharma1.48%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£144.561.0%
+UK£2.1b		39.9%PE28.8x
HLN HaleonUK£3.644.6%
+UK£1.4b		-3.6%PE19.3x
GSK GSKUK£20.151.6%
+UK£1.3b		43.4%PE13.8x
HCM HUTCHMED (China)UK£1.7811.3%
+UK£154.8m		-22.3%PE4.5x
HIK Hikma PharmaceuticalsUK£15.481.1%
+UK£36.2m		-21.8%PE11x

Latest News

AZN
UK£144.56
AstraZeneca
7D
1.0%
1Y
39.9%
EAH
UK£0.95
ECO Animal Health Group
7D
7.9%
1Y
59.2%
HCM
UK£1.78
HUTCHMED (China)
7D
11.3%
1Y
-22.3%
HLN
UK£3.64
Haleon
7D
4.6%
1Y
-3.6%
Narrative Update • Jul 01

HLN: Lower Forward P E Assumptions Will Pressure Future Share Price

Haleon’s analyst price target has been trimmed by £0.10 to £3.15, as analysts factor in a slightly lower assumed future P/E, alongside recent Street moves that have reduced targets and, in one case, shifted the stock to a Neutral stance. Analyst Commentary Recent Street research on Haleon points to a more cautious tone, with several bearish analysts trimming price targets and reassessing risk around valuation, execution and future growth assumptions.
POLB
UK£0.069
Poolbeg Pharma
7D
1.5%
1Y
110.8%
INC
UK£0.018
Incanthera
7D
-2.8%
1Y
-63.2%
GSK
UK£20.15
GSK
7D
1.6%
1Y
43.4%
HIK
UK£15.48
Hikma Pharmaceuticals
7D
1.1%
1Y
-21.8%
IMM
UK£0.035
ImmuPharma
7D
-6.6%
1Y
60.1%
ANCR
UK£3.34
Animalcare Group
7D
0.6%
1Y
13.4%
AGY
UK£0.066
Allergy Therapeutics
7D
-5.7%
1Y
-17.5%
NFX
UK£0.0018
Nuformix
7D
-10.0%
1Y
111.8%